期刊文献+

人乳腺癌易感基因突变和卵巢储备下降的探讨 被引量:4

Breast cancer susceptibility gene mutations and decreased ovarian reserve
原文传递
导出
摘要 人乳腺癌易感基因(BRCA)1和BRCA2的表达产物BRCA1和BRCA2蛋白是毛细血管扩张性共济失调突变基因(ATM)介导的DNA损伤修复信号通路成员,对DNA双链断裂同源重组修复至关重要。BRCA突变很大程度上增加了女性罹患乳腺癌、卵巢癌的风险。但对于BRCA突变产生的非癌症影响仍旧知之甚少。近年来有研究表明BRCA突变携带的女性可能出现卵巢储备下降。若BRCA突变与卵巢储备下降存在因果关系,则不仅有助于揭示遗传参与的卵巢衰老机制,甚至提示BRCA有望作为卵巢早衰的易感因素之一,有助于卵巢早衰的早期诊断。本文就近年来国内外的相关研究,对BRCA突变和卵巢储备功能下降作一探讨。 Breast cancer susceptibility gene(BRCA)1 and BRCA2 are menbers of the ATM-mediated DNA damage signalling pathway which are integral in the repair of DNA double strand breaks through homologous recombination. BRCA germline mutations substantially increase the risk of breast and ovarian cancer. But the non-cancer-related implications still remain less-known. A number of studies suggest that ovarian reserve may be reduced in BRCA mutation carriers. If the causal relationship between BRCA mutations and diminished ovarian reserve(DOR) is confirmed, it helps not only to recover the mechanism of ovarian aging but also the early diagnosis for premature ovarian failure(POF). Here is to make a review of the reseach status of BRCA germline mutation and diminished ovarian reserve.
作者 喻意 雷小云 王嘉宁 徐营 Yu Yi;Lei Xiaoyun;Wang Jianing;Xu Ying;(Medical College of Jiaxing University)
机构地区 嘉兴学院医学院
出处 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2018年第2期152-157,共6页 Chinese Journal of Reproduction and Contraception
基金 2017年浙江省大学生科技创新活动计划暨新苗人才计划项目(2017R417040) 嘉兴学院2016年度校级重点SRT计划项目(851716033)~~
关键词 人乳腺癌易感基因(BRCA) 卵巢储备下降(DOR) 卵母细胞衰老 DNA损伤修复 抗苗勒管激素(AMH) 卵巢早衰 Breast cancer susceptibility gene (BRCA) Diminished ovarian reserve (DOR) Oocyteaging DNA damage repair Anti-Mullerian homone (AMH) Premature ovarian failure (POF)
  • 相关文献

参考文献5

二级参考文献81

  • 1Gruijters MJ, Visser JA, Durlinger AL, et al. Anti-Müllerianhormone and its role in ovarian function. Mol Cell Endocrinol,2003, 211(1-2):85-90.
  • 2Pigny P, Merlen E, Robert Y, et al. Elevated serum levelof anti-Müllerian hormone in patients with polycystic ovarysyndrome: relationship to the ovarian follicle excess and tothe follicular arrest. J Clin Endocrinol Metab, 2003, 88(12):5957-62.
  • 3Vigier B, Picard JY, Tran D, et al. Production of anti-Müllerianhormone: another homology between Sertoli and granulosecells. Endocrinology, 1984, 144(4):1315-20.
  • 4Ueno S, Kuroda T, Maclaughlin DT, et al. Müllerian inhibitingsubstance in the adult rat ovary during various stages of theestrous cycle. Endocrinology, 1989, 125(2):1060-6.
  • 5Baarends WM, Uilenbroek JT, Kramer P, et al. Anti-Müllerianhormone and anti-Müllerian hormone type II receptormessenger ribonucleic acid expression in rat ovaries duringpostnatal development, the estrous cycle, and gonadotrophininducedfollicle growth. Endocrinology, 1995, 136(11):4951-62.
  • 6Weenen C, Laven JSE, von Bergh ARM, et al. Anti-Müllerianhormone expression pattern in the human ovary: potentialimplications for initial and cyclic follicle recruitment. MolHum Reprod, 2004, 10(2):77-83.
  • 7Durlinger AL, Kramer P, Karels B, et al. Control of primordialfollicle recruitment by anti-Müllerian hormone in mouseovary. Endocrinology, 1999, 140(12):5789-96.
  • 8Carlsson IB, Scott JE, Visser JA, et al. Anti-Müllerian hormoneinhibits initiation of growth of human primordial ovarianfollicles in vitro. Hum Reprod, 2006, 21(9):2223-7.
  • 9McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarianfollicle. Endoer Rev, 2000, 21(2):200-14.
  • 10Durlinger AL, Gruijter MJG, Kramer P, et al. Anti-Müllerianhormone attenuates the effect of follicle-stimulating hormoneon follicle development in the mouse ovary. Endocrinology,2001, 142(11):4891-9.

共引文献143

同被引文献38

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部